Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
The most critical limitation of VAERS: raw numbers are meaningless without context. Understanding why 1,000 reports from Vaccine A could be safer than 100 reports from Vaccine B.
VAERS' greatest limitation isn't what it contains — it's what it's missing:denominators. A denominator is the total number of doses administered of each vaccine. Without this crucial number, comparing adverse event rates across vaccines is not just difficult — it's impossible and potentially dangerous.
Consider this example: Vaccine A has 1,000 VAERS reports while Vaccine B has 100. Which is safer? Without knowing how many doses of each were given, you cannot tell. If Vaccine A was given to 10 million people and Vaccine B to 1,000 people, then Vaccine A is actually much safer (0.01% vs 10% adverse event rate).
COVID-19 vaccines provide the perfect illustration of the denominator problem. They account for roughly 57% of all VAERS reports ever filed — a staggering proportion that, without context, might suggest unusual safety concerns.
But context changes everything. With an estimated 670,000,000+ doses administered in the U.S., COVID-19 vaccines have a VAERS reporting rate of approximately1674 reports per million doses. This rate is actually within the typical range for vaccines in VAERS.
If denominators are so important, why doesn't VAERS include them? Several challenges make precise denominator data difficult to obtain:
Here are some examples of how raw VAERS numbers can mislead:
Pandemic vaccines often have more VAERS reports than seasonal vaccines — not because they're more dangerous, but because they're administered to more people in shorter timeframes with heightened public attention.
Adult vaccines may appear to have higher adverse event rates because adults are more likely to report symptoms and have more complex medical histories that can complicate attribution.
New vaccines often have higher reporting rates due to increased vigilance, media attention, and healthcare provider awareness — regardless of their actual safety profile.
The denominator problem is especially critical for death reports. COVID-19 vaccines have approximately 0.0 death reports per million doses administered. While each death represents a tragedy and warrants investigation, this rate provides crucial context.
For comparison, the background death rate in the U.S. population is approximately 8.7 deaths per 1,000 people per year. Among elderly populations (who received vaccines first), background death rates are much higher. This context is essential for interpreting death reports.
When researchers calculate adverse event rates using proper denominators, they consistently find:
Regulatory agencies use multiple strategies to address denominator limitations:
Raw VAERS numbers are frequently misused in media coverage and public discourse:
Understanding the denominator problem is perhaps the most important concept for anyone interpreting VAERS data. It explains: